The importance of clinical trial protocols

Article Sidebar

PDF
Published: Jun 19, 2024
DOI: https://doi.org/10.21876/hsjhci.v14.2024.e1520
Keywords:
Randomized Controlled Trial, Scholarly Communication

Main Article Content

Melissa Andreia de Moraes Silva
Hospital de Clínicas de Itajubá

Abstract

The International Committee of Medical Journal Editors (ICMJE) and the World Health Organization (WHO) define a clinical trial as any research that prospectively assigns participants or groups of human subjects to one or more interventions (medicines, procedures, devices, behavioral treatments, dietary supplements and diets, for example). These trials aim to evaluate the effects of interventions on human health. Prospective clinical research is essential for discovering new knowledge, improving the scientific base, solving challenges, and improving clinical practices. The basic principles for a successful researcher include interest, availability, persistence, and honesty. However, it is essential that, first of all, one has complete and detailed knowledge of scientific writing and preparation of the research protocol.

Article Details

How to Cite
1.
de Moraes Silva MA. The importance of clinical trial protocols. HSJ [Internet]. 2024Jun.19 [cited 2024Jul.2];14(1):e1520. Available from: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/hsjhci.v14.2024.e1520
Issue
Vol 14 (2024): Volume 14 - 2024
Section
EDITORIAL
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors maintain copyright and grant the HSJ the right to first publication. From 2024, the publications wiil be licensed under Attribution 4.0 International , allowing their sharing, recognizing the authorship and initial publication in this journal.

Authors are authorized to assume additional contracts separately for the non-exclusive distribution of the version of the work published in this journal (e.g., publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.

Authors are encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal page) at any point after the editorial process.

Also, the AUTHOR is informed and consents that the HSJ can incorporate his article into existing or future scientific databases and indexers, under the conditions defined by the latter at all times, which will involve, at least, the possibility that the holders of these databases can perform the following actions on the article.

Author Biography

Melissa Andreia de Moraes Silva, Hospital de Clínicas de Itajubá

Master and PhD in Sciences from the Federal University of São Paulo. Vascular Surgeon and Vascular Ultrasonographer. Responsible Editor for the Health Sciences Journal.

References

1. Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet. 2004;364(9438):911-2. http://doi.org/10.1016/S0140- 6736(04)17034-7. PMid:15364170.
2. Bagatin E, Miot HA. How to design and write a clini¬cal research protocol in Cosmetic Dermatology. An Bras Dermatol. 2012;88(1):69-75. https://doi.org/10.1590/S0365- 05962013000100008. PMid:23539006.
3. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18. http://doi. org/10.1186/1741-7015-8-18. PMid:20334633.
4. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža- Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200-7. http://doi.org/10.7326/0003-4819-158-3-201302050-00583. PMid:23295957.
5. ReBEC: Registro Brasileiro de Ensaios Clínicos. 2024 [cited 2024 June 5]. Available from: https://ensaiosclinicos.gov.br